Part ofhealthcare →

HR4299FEDERALin_committee

U.S. House of Representatives refers Protecting Patient Access to Cancer and Complex Therapies Act to committee

Original title: Protecting Patient Access to Cancer and Complex Therapies Act

July 7, 2025

healthcare cancer treatment medical access federal legislation

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Jul 7, 2025

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This referral marks the beginning of the legislative process for a bill that could impact insurance coverage and treatment availability for cancer patients and healthcare providers nationwide.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Cancer patients

The bill aims to address access to complex therapies, which directly impacts the treatment options available to this group.

Healthcare providers

Providers of complex therapies may be subject to new regulatory or reimbursement standards established by the bill.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

The Protecting Patient Access to Cancer and Act has been introduced and referred to the House Committees on Energy and Commerce and Ways and Means for review. This legislative step initiates the formal process to consider potential changes to the accessibility of specialized medical treatments.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This referral marks the beginning of the legislative process for a bill that could impact insurance coverage and treatment availability for cancer patients and healthcare providers nationwide.

Frequently Asked Questions

What does this bill do?

The provided document identifies the bill's title and its referral to committees, but does not detail the specific policy changes or requirements it proposes.

What is the current status of the bill?

As of July 7, 2025, the bill has been introduced and referred to the House Committees on Energy and Commerce and Ways and Means.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift70% confidence

Legislative focus on complex therapies

The introduction of this bill signals a legislative intent to examine the accessibility of high-cost or specialized cancer treatments.

Protecting Patient Access to Cancer and Complex Therapies Act

Connected Entities

organizationCommittee on Energy and Commerce“Congressional committee assigned to review the bill.”Map →

organizationCommittee on Ways and Means“Congressional committee assigned to review the bill.”Map →

Analysis Score

0–100

Significance40
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz20
Current news / social attention level

Publisher tools